James Dunyak
About James Dunyak
James Dunyak's Educational Background
James Dunyak holds an impressive array of academic qualifications. He earned a B.S. from Virginia Tech and an M.S. in Engineering Mechanics from Virginia Polytechnic Institute. Furthermore, he obtained a Ph.D. in Applied Mathematics/Probability Theory from the University of Maryland, showcasing his depth in mathematical sciences. To expand his expertise in biostatistics, he pursued an M.S. in Biostatistics from the Harvard T.H. Chan School of Public Health. Additionally, he holds an M.S. in Regulatory Affairs from Northeastern University, underlining his ability to navigate complex regulatory environments.
James Dunyak's Professional Experience
James Dunyak has held prominent leadership roles across various prestigious organizations. His career includes significant tenures in biostatistics, research and development, bioinformatics, and clinical pharmacometrics at Certara, AstraZeneca, Metamark Genetics, Novartis, and MITRE. These roles underline his vast experience in both the pharmaceutical and biotechnology sectors, contributing to advancements in precision medicine and commercial product development.
James Dunyak's Role at Texas Tech
James Dunyak served as a tenured Associate Professor in the Department of Mathematics and Statistics at Texas Tech. In this academic role, he was involved in teaching, mentoring, and conducting research in mathematical sciences. His tenure demonstrated his commitment to education and his ability to impart complex concepts to students, leveraging his extensive knowledge in applied mathematics and biostatistics.
James Dunyak and Precision Medicine
James Dunyak focuses on realizing the promise of precision medicine. He works on translating research achievements into viable commercial products within highly regulated environments. His emphasis on precision medicine highlights his commitment to advancing tailored healthcare solutions through rigorous statistical and mathematical methods, aimed at improving patient outcomes.